NO983812L - Nye kombinasjoner av aktive prinsipper inneholdende clopidogrel og et antitrombotisk middel - Google Patents
Nye kombinasjoner av aktive prinsipper inneholdende clopidogrel og et antitrombotisk middelInfo
- Publication number
- NO983812L NO983812L NO983812A NO983812A NO983812L NO 983812 L NO983812 L NO 983812L NO 983812 A NO983812 A NO 983812A NO 983812 A NO983812 A NO 983812A NO 983812 L NO983812 L NO 983812L
- Authority
- NO
- Norway
- Prior art keywords
- active principles
- pct
- antithrombotic agent
- new combinations
- containing clopidogrel
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/60—Salicylic acid; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/60—Salicylic acid; Derivatives thereof
- A61K31/618—Salicylic acid; Derivatives thereof having the carboxyl group in position 1 esterified, e.g. salsalate
- A61K31/621—Salicylic acid; Derivatives thereof having the carboxyl group in position 1 esterified, e.g. salsalate having the hydroxy group in position 2 esterified, e.g. benorylate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A61P5/36—Antigestagens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones
- A61P5/44—Glucocorticosteroids; Drugs increasing or potentiating the activity of glucocorticosteroids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR9602027A FR2744918B1 (fr) | 1996-02-19 | 1996-02-19 | Nouvelles associations de principes actifs contenant un derive de thieno(3,2-c)pyridine et un antithrombotique |
PCT/FR1997/000296 WO1997029753A1 (fr) | 1996-02-19 | 1997-02-17 | Nouvelles associations de principes actifs contenant du clopidogrel et un antithrombotique |
Publications (4)
Publication Number | Publication Date |
---|---|
NO983812D0 NO983812D0 (no) | 1998-08-19 |
NO983812L true NO983812L (no) | 1998-10-09 |
NO317747B1 NO317747B1 (no) | 2004-12-13 |
NO317747B3 NO317747B3 (no) | 2011-10-03 |
Family
ID=9489354
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO19983812A NO317747B3 (no) | 1996-02-19 | 1998-08-19 | Farmasoytisk preparat samt anvendelse derav |
NO2010015C NO2010015I2 (no) | 1996-02-19 | 2010-07-09 | Klopidogrel og acetylsalicylsyre eller famasøytiskaksepterbare salter derav |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO2010015C NO2010015I2 (no) | 1996-02-19 | 2010-07-09 | Klopidogrel og acetylsalicylsyre eller famasøytiskaksepterbare salter derav |
Country Status (29)
Country | Link |
---|---|
US (1) | US5989578A (no) |
EP (1) | EP0881901B1 (no) |
JP (1) | JP3662028B2 (no) |
KR (1) | KR100295345B1 (no) |
CN (1) | CN1116042C (no) |
AT (1) | ATE218870T1 (no) |
AU (1) | AU715655B2 (no) |
BR (1) | BR9707556A (no) |
CA (1) | CA2246289C (no) |
CZ (1) | CZ292363B6 (no) |
DE (2) | DE69713287T2 (no) |
DK (1) | DK0881901T3 (no) |
EE (1) | EE03513B1 (no) |
ES (1) | ES2176684T3 (no) |
FR (1) | FR2744918B1 (no) |
HK (1) | HK1017850A1 (no) |
HU (1) | HU225036B1 (no) |
IL (1) | IL125848A (no) |
IS (1) | IS1892B (no) |
NO (2) | NO317747B3 (no) |
NZ (1) | NZ331444A (no) |
PL (1) | PL187292B1 (no) |
PT (1) | PT881901E (no) |
RU (1) | RU2184547C2 (no) |
SI (1) | SI0881901T1 (no) |
SK (1) | SK284285B6 (no) |
TR (1) | TR199801608T2 (no) |
UA (1) | UA51695C2 (no) |
WO (1) | WO1997029753A1 (no) |
Families Citing this family (35)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2322824A1 (en) * | 1998-03-13 | 1999-09-16 | Merck & Co., Inc. | Combination therapy and composition for acute coronary ischemic syndrome and related conditions |
WO1999065500A1 (en) | 1998-06-17 | 1999-12-23 | Bristol-Myers Squibb Company | Preventing cerebral infarction through administration of adp-receptor antiplatelet and antihypertensive drugs in combination |
US6509348B1 (en) | 1998-11-03 | 2003-01-21 | Bristol-Myers Squibb Company | Combination of an ADP-receptor blocking antiplatelet drug and a thromboxane A2 receptor antagonist and a method for inhibiting thrombus formation employing such combination |
FR2792836B3 (fr) | 1999-04-30 | 2001-07-27 | Sanofi Sa | Composition pharmaceutique sous forme unitaire contenant de l'aspirine et de l'hydrogenosulfate de clopidogrel |
FR2797400A1 (fr) * | 1999-08-11 | 2001-02-16 | Sanofi Synthelabo | Associations a activite anti-thrombotique constituees de l'hydrogenosulfate de clopidogrel et d'un antagoniste des recepteurs gpiib/iiia et les compositions pharmaceutiques les contenant |
PL206138B1 (pl) * | 2000-12-25 | 2010-07-30 | Daiichi Sankyo Company Limiteddaiichi Sankyo Company Limited | Kompozycja farmaceutyczna zawierająca aspirynę oraz zestaw i zastosowanie składników kompozycji |
SE0101932D0 (sv) * | 2001-05-31 | 2001-05-31 | Astrazeneca Ab | Pharmaceutical combinations |
FR2832929A1 (fr) * | 2001-12-05 | 2003-06-06 | Sanofi Synthelabo | Compositions pharmaceutiques contenant un agent antithrombotique et un derive d'amines cycliques |
AU2003270861A1 (en) * | 2002-10-02 | 2004-04-23 | Bristol-Myers Squibb Company | Novel combination of a factor xa inhibitor and clopidogrel |
US20070243632A1 (en) * | 2003-07-08 | 2007-10-18 | Coller Barry S | Methods for measuring platelet reactivity of patients that have received drug eluting stents |
ATE536889T1 (de) | 2003-07-08 | 2011-12-15 | Accumetrics Inc | Kontrollierte thrombozyten-aktivierung zur überwachung der behandlung von adp-antagonisten |
HUP0400982A2 (en) * | 2004-05-17 | 2006-08-28 | Chemor Kutato | New veterinary product for honeybees |
US20060222640A1 (en) * | 2005-03-29 | 2006-10-05 | Boehringer Ingelheim International Gmbh | New pharmaceutical compositions for treatment of thrombosis |
EP1926736A4 (en) * | 2005-09-21 | 2010-08-25 | Chong Kun Dang Pharm Corp | NEW RESINATE COMPLEX OF S-CLOPIDOGREL AND METHOD FOR THE PRODUCTION THEREOF |
WO2008048083A1 (es) * | 2006-10-17 | 2008-04-24 | Espinosa Abdala Leopoldo De Je | Composiciones farmacéuticas para el tratamiento de enfermedades tromboembólicas |
DE102006051625A1 (de) | 2006-11-02 | 2008-05-08 | Bayer Materialscience Ag | Kombinationstherapie substituierter Oxazolidinone |
KR20160033792A (ko) | 2007-04-27 | 2016-03-28 | 사이덱스 파마슈티칼스, 인크. | 클로피도그렐 및 설포알킬 에테르 사이클로덱스트린을 함유하는 제형 및 사용 방법 |
KR100949273B1 (ko) * | 2008-02-22 | 2010-03-25 | 한올제약주식회사 | 복합제제 |
DE102008032361A1 (de) * | 2008-07-10 | 2010-01-21 | Csl Behring Gmbh | Der Einsatz von Faktor VIII und vWF bzw. vWF-enthaltenden Konzentraten zur Therapie der durch Thrombocyten-Inhibitoren induzierte Koagulopathie |
US8236782B2 (en) * | 2009-05-13 | 2012-08-07 | Cydex Pharmaceuticals, Inc. | Pharmaceutical compositions comprising prasugrel and cyclodextrin derivatives and methods of making and using the same |
EA021588B1 (ru) | 2009-06-25 | 2015-07-30 | Тетра Сиа | Бетаиновые соли ацетилсалициловой кислоты |
US8563574B2 (en) | 2009-12-07 | 2013-10-22 | Academic Pharmaceuticals, Inc. | Parenteral formulation of clopidogrel |
CN102389436A (zh) * | 2011-09-09 | 2012-03-28 | 北京阜康仁生物制药科技有限公司 | 一种抗血小板聚集的药物组合物 |
KR101675501B1 (ko) * | 2011-11-02 | 2016-11-14 | 한국유나이티드제약 주식회사 | 클로피도그렐 및 아스피린의 복합제제 |
US8513278B2 (en) | 2011-11-26 | 2013-08-20 | Academic Pharmaceuticals, Inc. | Parenteral dextrose formulation of clopidogrel |
CN102406938A (zh) * | 2011-11-29 | 2012-04-11 | 北京阜康仁生物制药科技有限公司 | 一种抗血栓的药物组合物 |
WO2013133620A1 (en) * | 2012-03-09 | 2013-09-12 | Yuhan Corporation | Pharmaceutical composition comprising clopidogrel and aspirin and process for preparing the same |
CN103720700A (zh) * | 2012-10-10 | 2014-04-16 | 江苏威凯尔医药科技有限公司 | 含有阿斯匹林和维卡格雷的药用组合物 |
EP2796145B1 (en) | 2013-04-22 | 2017-11-01 | CSL Ltd. | A covalent complex of von willebrand factor and faktor viii linked by a disulphide bridge |
KR101502588B1 (ko) | 2013-05-01 | 2015-03-16 | 한국유나이티드제약 주식회사 | 클로피도그렐 및 아스피린의 복합제제 |
WO2015015062A1 (fr) * | 2013-08-02 | 2015-02-05 | Sanofi | Comprime pharmaceutique comprenant de l'acide acetylsalicylique et du clopidogrel |
HUP1400294A2 (hu) | 2014-06-13 | 2015-12-28 | Skillpharm Kft | Clopidogrel új alkalmazása |
CN107698620A (zh) * | 2015-06-23 | 2018-02-16 | 江苏天士力帝益药业有限公司 | 一种氘代噻吩并哌啶衍生物、制备方法及其应用 |
RU2745774C1 (ru) * | 2020-08-14 | 2021-03-31 | Алексей Викторович Марочков | Способ лечения пациентов с новой коронавирусной инфекцией (covid-19) |
US20230059869A1 (en) | 2021-08-03 | 2023-02-23 | Liqmeds Worldwide Limited | Oral pharmaceutical solution of clopidogrel |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2307538A1 (fr) * | 1975-04-18 | 1976-11-12 | Centre Etd Ind Pharma | Nouveau medicament anti-agregant plaquettaire |
-
1996
- 1996-02-19 FR FR9602027A patent/FR2744918B1/fr not_active Expired - Fee Related
-
1997
- 1997-02-17 EE EE9800247A patent/EE03513B1/xx not_active IP Right Cessation
- 1997-02-17 HU HU9901144A patent/HU225036B1/hu active Protection Beyond IP Right Term
- 1997-02-17 IL IL12584897A patent/IL125848A/xx not_active IP Right Cessation
- 1997-02-17 WO PCT/FR1997/000296 patent/WO1997029753A1/fr active IP Right Grant
- 1997-02-17 CA CA002246289A patent/CA2246289C/fr not_active Expired - Lifetime
- 1997-02-17 JP JP52906097A patent/JP3662028B2/ja not_active Expired - Lifetime
- 1997-02-17 RU RU98117511/14A patent/RU2184547C2/ru active
- 1997-02-17 SK SK1105-98A patent/SK284285B6/sk not_active IP Right Cessation
- 1997-02-17 PL PL97327923A patent/PL187292B1/pl unknown
- 1997-02-17 NZ NZ331444A patent/NZ331444A/en not_active IP Right Cessation
- 1997-02-17 AT AT97905218T patent/ATE218870T1/de active
- 1997-02-17 SI SI9730355T patent/SI0881901T1/xx unknown
- 1997-02-17 CZ CZ19982499A patent/CZ292363B6/cs not_active IP Right Cessation
- 1997-02-17 UA UA98094800A patent/UA51695C2/uk unknown
- 1997-02-17 DE DE69713287T patent/DE69713287T2/de not_active Expired - Lifetime
- 1997-02-17 CN CN97192393A patent/CN1116042C/zh not_active Expired - Lifetime
- 1997-02-17 DK DK97905218T patent/DK0881901T3/da active
- 1997-02-17 KR KR1019980706556A patent/KR100295345B1/ko not_active IP Right Cessation
- 1997-02-17 AU AU18844/97A patent/AU715655B2/en not_active Revoked
- 1997-02-17 DE DE201012000030 patent/DE122010000030I2/de active Active
- 1997-02-17 EP EP97905218A patent/EP0881901B1/fr not_active Expired - Lifetime
- 1997-02-17 BR BR9707556A patent/BR9707556A/pt not_active IP Right Cessation
- 1997-02-17 PT PT97905218T patent/PT881901E/pt unknown
- 1997-02-17 US US09/117,904 patent/US5989578A/en not_active Expired - Lifetime
- 1997-02-17 TR TR1998/01608T patent/TR199801608T2/xx unknown
- 1997-02-17 ES ES97905218T patent/ES2176684T3/es not_active Expired - Lifetime
-
1998
- 1998-08-18 IS IS4827A patent/IS1892B/is unknown
- 1998-08-19 NO NO19983812A patent/NO317747B3/no not_active IP Right Cessation
-
1999
- 1999-07-08 HK HK99102920A patent/HK1017850A1/xx not_active IP Right Cessation
-
2010
- 2010-07-09 NO NO2010015C patent/NO2010015I2/no unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO983812L (no) | Nye kombinasjoner av aktive prinsipper inneholdende clopidogrel og et antitrombotisk middel | |
DE68925814D1 (de) | Hydrogeniertes block-copolymer und dessen zusammensetzung | |
MX9600857A (es) | Forma de dosificacion i en tabletas, con unidades multiples. | |
MY128809A (en) | Pharmaceutical formulation of omeprazole | |
BR9406893A (pt) | Emprego de nona- e decapeptideos para a preparação de um medicamento para o combate da aids | |
PL323490A1 (en) | Tetralinic compounds exibiting acitity against multgiple-drug refractoriness | |
NO307092B1 (no) | Sordaridin-derivater, anvendelse derav og farmasoeytisk blanding | |
RS49599B (sr) | Upotreba inhibitora h+, k+-atp-aze i glukokortikoida i farmaceutska formulacija | |
GEP20063719B (en) | Prevention of Migraine Recurrence | |
DK0748222T3 (da) | Hostestillende sammensætning, som indeholder hostestillende middel og benzydamin | |
IL110724A0 (en) | Retroviral protease inhibitors, their preparation and pharmaceutical compositions containing them | |
MX9709453A (es) | Composicion farmaceutica oral de compuestos de piperidinoalcanol en forma de solucion. | |
NO308842B1 (no) | Nye retinoider, anvendelse derav, og farmasøytiske preparater inneholdende dem | |
GB9802542D0 (en) | New use | |
TW333453B (en) | Pharmaceutical composition comprising toremifene for use in the treatment of autoimmune diseases | |
AU8430791A (en) | Aromatic sulfonamide derivatives, their use as enzyme inhibitors and pharmaceutical compositions containing them | |
ITMI911653A1 (it) | Derivati dell'eseridina ad attivita' anticolinesterasi, procedimento per la loro preparazione e composizioni farmaceutiche che li contengono. | |
HUP9701598A2 (hu) | Gyógyszerkészítmény | |
ZA942972B (en) | New quinoxalinedione derivatives, their production and use in pharmaceutical agents. | |
ITMI922832A1 (it) | DERIVATI DELL'ESEROLINA AD ATTIVITAy ANTICOLINESTERASICA, PROCEDIMENTO PER LA LORO PREPARAZIONE E COMPOSIZIONI FARMACEUTICHE CHE LI CONTENGONO. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
SPCF | Filing of supplementary protection certificate |
Free format text: PRODUCT NAME: SAMMENSETNINGEN AV KLOPIDOGREL OG ACETYLSALICYLSYRE (ASPIRIN) ER PRODUKTET AV STOFFENE DUOPLAVIN OG DUOCOVER. KLOPIDOGREL OG ACETYLSALICYLSYRE OMFATTES I.A. AV GRUNDPATENTETS KRAV 1. SE OGSA THE MERCK INDEX; NAT. REG. NO/DATE: EU/1/10/619/001/NO 20100323; FIRST REG. NO/DATE: EU/1/10/619/001-014 20100315 Spc suppl protection certif: 2010015 Filing date: 20100709 |
|
LC4 | Limitation of patent rights - b3 (par. 39b patent act) |
Effective date: 20111003 |
|
SPCG | Granted supplementary protection certificate |
Free format text: PRODUCT NAME: SAMMENSETNINGEN AV KLOPIDOGREL OG ACETYLSALICYLSYRE (ASPIRIN) ER PRODUKTET AV STOFFENE DUOPLAVIN OG DUOCOVER. KLOPIDOGREL OG ACETYLSALICYLSYRE OMFATTES I.A. AV GRUNDPATENTETS KRAV 1. SE OGSA THE MERCK INDEX; NAT. REG. NO/DATE: EU/1/10/619/001/NO 20100323; FIRST REG. NO/DATE: EU/1/10/619/001-014 20100315 Spc suppl protection certif: 2010015 Filing date: 20100709 Extension date: 20220217 |
|
MK1K | Patent expired |